P
PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
KOSDAQ:214450
Price:
342 000
KRW
-2.15%
Market Closed
Market Cap:
₩3.6T
Balance Sheet
Balance Sheet Decomposition
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Balance Sheet Decomposition is not available for
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Balance Sheet
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Currency: KRW
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
3 912
|
7 985
|
9 890
|
14 864
|
17 634
|
16 990
|
21 096
|
19 738
|
26 715
|
41 674
|
72 931
|
67 245
|
165 348
|
|
| Cash |
1
|
0
|
0
|
1
|
2
|
6
|
0
|
2
|
5
|
3
|
8
|
67 245
|
165 348
|
|
| Cash Equivalents |
3 911
|
7 985
|
9 890
|
14 863
|
17 632
|
16 984
|
21 096
|
19 736
|
26 710
|
41 672
|
72 923
|
0
|
0
|
|
| Short-Term Investments |
1 080
|
61
|
13
|
108 181
|
92 349
|
70 622
|
54 301
|
49 292
|
52 552
|
115 123
|
111 412
|
93 053
|
272 003
|
|
| Total Receivables |
2 167
|
3 648
|
6 255
|
5 850
|
10 782
|
18 358
|
17 243
|
20 589
|
26 351
|
30 510
|
36 415
|
36 330
|
56 624
|
|
| Accounts Receivables |
2 145
|
2 673
|
4 610
|
5 725
|
10 689
|
15 310
|
16 028
|
20 225
|
22 890
|
27 928
|
33 202
|
31 812
|
40 500
|
|
| Other Receivables |
22
|
975
|
1 645
|
125
|
93
|
3 048
|
1 215
|
364
|
3 461
|
2 582
|
3 213
|
4 519
|
16 124
|
|
| Inventory |
2 357
|
2 152
|
2 197
|
4 783
|
5 445
|
5 119
|
12 294
|
13 928
|
20 781
|
17 342
|
24 453
|
50 232
|
57 325
|
|
| Other Current Assets |
1 035
|
68
|
659
|
538
|
259
|
1 247
|
836
|
926
|
1 005
|
2 142
|
2 134
|
9 604
|
3 241
|
|
| Total Current Assets |
10 551
|
13 916
|
19 014
|
134 214
|
126 468
|
112 335
|
105 769
|
104 473
|
127 404
|
206 792
|
247 345
|
256 465
|
554 542
|
|
| PP&E Net |
6 142
|
9 085
|
21 023
|
20 396
|
20 771
|
27 179
|
66 064
|
73 886
|
94 046
|
109 481
|
117 960
|
123 061
|
147 313
|
|
| PP&E Gross |
0
|
9 085
|
21 023
|
20 396
|
20 771
|
27 179
|
66 064
|
73 886
|
94 046
|
109 481
|
117 960
|
123 061
|
147 313
|
|
| Accumulated Depreciation |
0
|
658
|
1 402
|
2 442
|
3 773
|
5 021
|
7 778
|
12 166
|
15 677
|
21 839
|
26 837
|
34 079
|
42 512
|
|
| Intangible Assets |
436
|
712
|
1 583
|
1 647
|
2 289
|
2 284
|
31 980
|
29 806
|
26 811
|
26 025
|
24 017
|
20 323
|
19 536
|
|
| Goodwill |
0
|
0
|
0
|
0
|
1 918
|
1 036
|
13 738
|
13 738
|
12 492
|
16 764
|
13 810
|
11 652
|
13 856
|
|
| Note Receivable |
145
|
0
|
0
|
0
|
0
|
0
|
1 000
|
3 624
|
0
|
4 794
|
4 434
|
3 938
|
2 342
|
|
| Long-Term Investments |
460
|
460
|
2 471
|
12 905
|
27 652
|
45 048
|
37 150
|
40 552
|
54 395
|
58 268
|
59 361
|
112 777
|
105 746
|
|
| Other Long-Term Assets |
115
|
343
|
294
|
144
|
233
|
1 151
|
2 488
|
3 847
|
4 684
|
5 523
|
11 128
|
7 066
|
12 367
|
|
| Other Assets |
0
|
0
|
0
|
0
|
1 918
|
1 036
|
13 738
|
13 738
|
12 492
|
16 764
|
13 810
|
11 652
|
13 856
|
|
| Total Assets |
17 849
N/A
|
24 516
+37%
|
44 385
+81%
|
169 306
+281%
|
179 332
+6%
|
189 034
+5%
|
258 188
+37%
|
269 925
+5%
|
319 831
+18%
|
427 647
+34%
|
478 055
+12%
|
535 281
+12%
|
855 701
+60%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
2 572
|
625
|
1 272
|
1 064
|
2 029
|
1 732
|
4 457
|
5 359
|
1 876
|
2 939
|
3 527
|
2 831
|
11 081
|
|
| Accrued Liabilities |
0
|
88
|
131
|
135
|
179
|
115
|
333
|
492
|
534
|
703
|
860
|
974
|
1 493
|
|
| Short-Term Debt |
100
|
0
|
2 500
|
0
|
0
|
0
|
0
|
0
|
15 000
|
15 800
|
15 550
|
400
|
250
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
3 210
|
0
|
0
|
0
|
3 019
|
3 507
|
4 581
|
4 961
|
5 024
|
32 606
|
12 231
|
|
| Other Current Liabilities |
841
|
1 955
|
3 507
|
5 960
|
3 999
|
5 016
|
7 671
|
9 232
|
13 858
|
23 602
|
29 292
|
29 088
|
57 763
|
|
| Total Current Liabilities |
3 514
|
2 668
|
10 620
|
7 158
|
6 207
|
6 863
|
15 480
|
18 590
|
35 849
|
48 005
|
54 253
|
65 899
|
82 818
|
|
| Long-Term Debt |
4 623
|
6 855
|
8 997
|
5 401
|
0
|
0
|
17 343
|
17 435
|
12 829
|
44 850
|
46 194
|
1 301
|
196 985
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
114
|
0
|
6 061
|
5 404
|
4 746
|
4 514
|
3 741
|
2 794
|
2 156
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
824
|
3 299
|
21 250
|
19 349
|
18 989
|
22 917
|
28 153
|
29 091
|
30 038
|
|
| Other Liabilities |
210
|
65
|
0
|
0
|
546
|
19
|
430
|
73
|
1 996
|
1 919
|
2 211
|
3 092
|
4 301
|
|
| Total Liabilities |
8 347
N/A
|
9 588
+15%
|
19 617
+105%
|
12 559
-36%
|
7 691
-39%
|
10 181
+32%
|
60 565
+495%
|
60 851
+0%
|
74 409
+22%
|
122 205
+64%
|
134 552
+10%
|
102 178
-24%
|
316 299
+210%
|
|
| Equity | ||||||||||||||
| Common Stock |
850
|
850
|
3 005
|
4 582
|
4 733
|
4 733
|
4 733
|
4 777
|
4 895
|
5 056
|
5 056
|
5 160
|
5 255
|
|
| Retained Earnings |
7 466
|
13 128
|
21 965
|
34 843
|
46 859
|
56 994
|
69 027
|
82 783
|
112 615
|
154 018
|
190 862
|
260 787
|
343 061
|
|
| Additional Paid In Capital |
1 187
|
950
|
0
|
116 629
|
121 893
|
121 893
|
122 113
|
124 366
|
131 120
|
150 127
|
155 297
|
172 641
|
194 525
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
3
|
76
|
166
|
86
|
237
|
104
|
803
|
4 840
|
3 820
|
3 056
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
2 684
|
4 987
|
267
|
5 260
|
5 260
|
5 260
|
5 260
|
4 638
|
4 638
|
|
| Other Equity |
0
|
0
|
203
|
689
|
763
|
54
|
1 932
|
2 171
|
1 950
|
2 303
|
2 388
|
3 033
|
4 255
|
|
| Total Equity |
9 503
N/A
|
14 928
+57%
|
24 768
+66%
|
156 747
+533%
|
171 641
+10%
|
178 853
+4%
|
197 623
+10%
|
209 075
+6%
|
245 423
+17%
|
305 442
+24%
|
343 503
+12%
|
433 104
+26%
|
539 402
+25%
|
|
| Total Liabilities & Equity |
17 849
N/A
|
24 516
+37%
|
44 385
+81%
|
169 306
+281%
|
179 332
+6%
|
189 034
+5%
|
258 188
+37%
|
269 925
+5%
|
319 831
+18%
|
427 647
+34%
|
478 055
+12%
|
535 281
+12%
|
855 701
+60%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
2
|
2
|
6
|
9
|
9
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
|
| Preferred Shares Outstanding |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
